All Columns articles – Page 9
-
-
-
OpinionWhen regulatory cooperation goes too far, we all lose
Were FDA staff unduly influenced by Biogen in approving Alzheimer’s antibody?
-
-
OpinionThe impact of shipping delays on chemical industries
Supply chain difficulties don’t only affect supermarkets
-
OpinionHooray for milk
We’re still uncovering the secrets of breast milk, but what we know so far is fascinating
-
OpinionReverse combustion is preparing for takeoff
Where burning hydrocarbons is unavoidable, creating them from atmospheric carbon is a promising option
-
-
-
OpinionWeininger’s Smiles
The man whose code – and attitude to life – brought much happiness to chemists
-
OpinionAll work and no play
Is the long-hours culture of academic organic chemistry laboratories finally changing?
-
OpinionThe dead of aconite
Whether human, witch or werewolf, beware a flower known as the queen of poisons
-
OpinionA vaccine for all seasons?
Phase 1 clinical trials have begun on a candidate that could work against a wide range of flu viruses
-
OpinionTimmers’ towers and Straus’ flasks
The revolutionary system that made labs much less likely to go up in flames
-
OpinionMonitoring rainwater quality in Arizona
Community health workers are vital knowledge brokers
-
OpinionWhere are the Covid-19 drugs?
Small molecules appear to be lagging behind development of vaccine and antibody treatments
-
OpinionScience as a product of culture
The role of background beliefs and assumptions in the development of science
-
-
OpinionHidden details in iconic portrait of Lavoisiers reveal fears of coming revolution
As the French Revolution neared the Lavoisiers were reimagined as scientific progressives rather than out of touch aristocrats
-
OpinionThe price of failure
Drug market structures and high R&D failure rates can tempt companies into bad pricing behaviour